A rapid review of current engagement strategies with people who use drugs in monitoring and reporting on substance use-related harms.

Community engagement Data monitoring Data reporting Information systems Opioids Overdose crisis People who use drugs Substance use-related harm

Journal

Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624

Informations de publication

Date de publication:
14 11 2023
Historique:
received: 05 05 2023
accepted: 07 11 2023
medline: 16 11 2023
pubmed: 15 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

The Canadian drug supply has significantly increased in toxicity over the past few years, resulting in the worsening of the overdose crisis. A key initiative implemented during this crisis has been data monitoring and reporting of substance use-related harms (SRH). This literature review aims to: (1) identify strategies used for the meaningful engagement of people who use drugs (PWUD) in local, provincial, and national SRH data system planning, reporting, and action and (2) describe data monitoring and reporting strategies and common indicators of SRH within those systems. We searched three academic and five gray literature databases for relevant literature published between 2012 and 2022. Team members who identify as PWUD and a librarian at Public Health Ontario developed search strings collaboratively. Two reviewers screened all search results and applied the eligibility criteria. We used Microsoft Excel for data management. Twenty-two articles met our eligibility criteria (peer-reviewed n = 10 and gray literature reports n = 12); most used qualitative methods and focused on the Canadian context (n = 20). There were few examples of PWUD engaged as authors of reports on SRH monitoring. Among information systems involving PWUD, we found two main strategies: (1) community-based strategies (e.g., word of mouth, through drug sellers, and through satellite workers) and (2) public health-based data monitoring and communication strategies (e.g., communicating drug quality and alerts to PWUD). Substance use-related mortality, hospitalizations, and emergency department visits were the indicators most commonly used in systems of SRH reporting that engaged PWUD. This review demonstrates limited engagement of PWUD and silos of activity in existing SRH data monitoring and reporting strategies. Future work is needed to better engage PWUD in these processes in an equitable manner. Building SRH monitoring systems in partnership with PWUD may increase the potential impact of these systems to reduce harms in the community.

Sections du résumé

BACKGROUND
The Canadian drug supply has significantly increased in toxicity over the past few years, resulting in the worsening of the overdose crisis. A key initiative implemented during this crisis has been data monitoring and reporting of substance use-related harms (SRH). This literature review aims to: (1) identify strategies used for the meaningful engagement of people who use drugs (PWUD) in local, provincial, and national SRH data system planning, reporting, and action and (2) describe data monitoring and reporting strategies and common indicators of SRH within those systems.
METHODS
We searched three academic and five gray literature databases for relevant literature published between 2012 and 2022. Team members who identify as PWUD and a librarian at Public Health Ontario developed search strings collaboratively. Two reviewers screened all search results and applied the eligibility criteria. We used Microsoft Excel for data management.
RESULTS
Twenty-two articles met our eligibility criteria (peer-reviewed n = 10 and gray literature reports n = 12); most used qualitative methods and focused on the Canadian context (n = 20). There were few examples of PWUD engaged as authors of reports on SRH monitoring. Among information systems involving PWUD, we found two main strategies: (1) community-based strategies (e.g., word of mouth, through drug sellers, and through satellite workers) and (2) public health-based data monitoring and communication strategies (e.g., communicating drug quality and alerts to PWUD). Substance use-related mortality, hospitalizations, and emergency department visits were the indicators most commonly used in systems of SRH reporting that engaged PWUD.
CONCLUSION
This review demonstrates limited engagement of PWUD and silos of activity in existing SRH data monitoring and reporting strategies. Future work is needed to better engage PWUD in these processes in an equitable manner. Building SRH monitoring systems in partnership with PWUD may increase the potential impact of these systems to reduce harms in the community.

Identifiants

pubmed: 37964286
doi: 10.1186/s12954-023-00902-x
pii: 10.1186/s12954-023-00902-x
pmc: PMC10648706
doi:

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

169

Informations de copyright

© 2023. Crown.

Références

Healthc Q. 2022 Jul;25(2):7-12
pubmed: 36153678
Harm Reduct J. 2022 Jan 11;19(1):3
pubmed: 35012557
Can J Public Health. 2019 Apr;110(2):227-235
pubmed: 30610564
Int J Drug Policy. 2015 Dec;26(12):1251-7
pubmed: 26205676
Int J Drug Policy. 2021 Jan;87:102845
pubmed: 33246303
BMC Public Health. 2021 Jun 16;21(1):1156
pubmed: 34134698
Int J Drug Policy. 2019 Apr;66:15-22
pubmed: 30685650
Int J Drug Policy. 2020 Apr;78:102695
pubmed: 32143185
Int J Drug Policy. 2019 Nov;73:199-207
pubmed: 31542327
Harm Reduct J. 2022 Jul 5;19(1):73
pubmed: 35790994
Int J Drug Policy. 2022 Nov;109:103852
pubmed: 36122483
Drug Alcohol Depend. 2019 May 1;198:1-6
pubmed: 30856370
Int J Drug Policy. 2019 Sep;71:125-132
pubmed: 31336258
Harm Reduct J. 2019 Jun 10;16(1):37
pubmed: 31182099
Soc Sci Med. 2019 Mar;225:60-68
pubmed: 30798157
Int J Drug Policy. 2019 Dec;74:160-169
pubmed: 31610451
Health Promot Chronic Dis Prev Can. 2018 Sep;38(9):312-316
pubmed: 30226724
Harm Reduct J. 2020 May 7;17(1):27
pubmed: 32381011
JAMA Health Forum. 2021 Jan 4;2(1):e210001
pubmed: 36218421

Auteurs

Melissa Perri (M)

Dalla Lana School of Public Health, University of Toronto, 480 University Ave, Suite 300, Toronto, ON, M5G 1V2, Canada.

Triti Khorasheh (T)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, ON, Canada.

David Edward-Ooi Poon (DE)

Dalla Lana School of Public Health, University of Toronto, 480 University Ave, Suite 300, Toronto, ON, M5G 1V2, Canada.

Nat Kaminski (N)

Ontario Network of People Who Use Drugs, ON, Canada.

Sean LeBlanc (S)

Ontario Network of People Who Use Drugs, ON, Canada.

Leticia Mizon (L)

Ontario Network of People Who Use Drugs, ON, Canada.

Ashley Smoke (A)

Ontario Network of People Who Use Drugs, ON, Canada.

Carol Strike (C)

Dalla Lana School of Public Health, University of Toronto, 480 University Ave, Suite 300, Toronto, ON, M5G 1V2, Canada.
MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada.

Pamela Leece (P)

Dalla Lana School of Public Health, University of Toronto, 480 University Ave, Suite 300, Toronto, ON, M5G 1V2, Canada. Pamela.Leece@oahpp.ca.
Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, ON, Canada. Pamela.Leece@oahpp.ca.
Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. Pamela.Leece@oahpp.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH